[1]
Cruz Barrios, M. and Furones Mourelle, J. 2019. Benefit-risk use of transfer factor (Hebertrans®) in usual medical practice. Horizonte Sanitario. 18, 2 (Apr. 2019), 235–242. DOI:https://doi.org/10.19136/hs.a18n2.2918.